Investor Relations (IR) Questions: BioCryst Pharmacetuicals $BCRX

1) When is the last time BCRX raised cash through an offering (diluted)?In November 2009, we sold 5 million shares at an offering price of $9.75. Our S-3 is active and the ATM vehicle attached to it is a functioning means to sell BCRX at market prices at any time, assuming there is no regulatory restriction precluding a sale. We did use the ATM in the fourth quarter of 2011 for the first time since its inception in June/July 2011, and at various times over the last five quarters. During 1Q13, we sold an insignificant number of shares.

2) How much cash (not cash equivalents) does BCRX have?$14.8 million as of 3/31/13$28.3 million of cash, cash equivalents & investments as of 3/31/13

4) What is BCRX's quarterly cash burn?Our outlook for FY13 is operating cash use of $22-26 million.Operating cash use excludes any impact of our royalty monetization, hedge collateral posted or returned, sale of stock in the marketplace, and any other non-routine cash outflows or inflows, like restructuring and transaction costs

5) Does BCRX have an existing line of credit and if so how much can they draw against it?BCRX does not have an existing line of credit